World's Best Scientists 2026 revealed!
Lois M. Mulligan

Lois M. Mulligan

D-Index & Metrics

Genetics

D-Index
57
Citations
16478
World Ranking
3375
National Ranking
130

Lois M. Mulligan publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Lois M. Mulligan sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 154 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Lois M. Mulligan D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Lois M. Mulligan sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 57 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Lois M. Mulligan is affiliated with Queen's University in Canada and has conducted research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work includes a focus on several subfields such as Cell Biology, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, and Endocrinology, Diabetes and Metabolism.

Their research topics span a range of cellular and molecular processes, including:

  • Cellular transport and secretion
  • Ubiquitin and proteasome pathways
  • Caveolin-1 and cellular processes
  • Microtubule and mitosis dynamics
  • Hormonal regulation and hypertension
  • Adrenal and paraganglionic tumors
  • Lung cancer treatments and mutations

They have published in several scientific venues, with frequent contributions to:

  • Cancer Research
  • eLife
  • Endocrine Related Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Endocrine Abstracts

Their recent publications include:

  • TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation (2023), published in Cell Reports
  • Selpercatinib: First approved selective RET inhibitor (2023), published in Cell
  • RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma (2020), published in Oncogene
  • RET isoform-specific interaction with scaffold protein Ezrin promotes cell migration and chemotaxis in lung adenocarcinoma (2020), published in Lung Cancer
  • Evaluating Cell Membrane Localization and Intracellular Transport of Proteins by Biotinylation (2022), published in Methods in Molecular Biology

Frequent co-authors collaborating with Lois M. Mulligan are:

  • Brandy D. Hyndman
  • Timothy J. Walker
  • Eduardo Reyes-Alvarez
  • Costin N. Antonescu
  • Qianjin Guo

Best Publications

  • Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

    L M Mulligan;J B Kwok;C S Healey;M J Elsdon

  • The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

    Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir

  • Mutations of the RET proto-oncogene in Hirschsprung's disease

    Patrick Edery;Stanislas Lyonnet;Lois M. Mulligan;Anna Pelet

  • Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

    Lois M. Mulligan;Lois M. Mulligan;Charis Eng;Catherine S. Healey;David Clayton

  • Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

    C Eng;D P Smith;L M Mulligan;M A Nagai

  • RET revisited: expanding the oncogenic portfolio

    Lois M. Mulligan

  • Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast

    Aurel Perren;Liang Ping Weng;Alexander H. Boag;Ulricke Ziebold

  • Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease

    Tania Attié;Anna Pelet;Patrick Edery;Charis Eng;Charis Eng

  • Mechanisms of p53 loss in human sarcomas.

    Lois M. Mulligan;Greg J. Matlashewski;Heidi J. Scrable;Webster K. Cavenee

  • Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

    L. M. Mulligan;D. J. Marsh;B. G. Robinson;I. Schuffenecker

  • A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC

    Charis Eng;D. P. Smith;L. M. Mulligan;C. S. Healey

  • Multiple endocrine neoplasia type 2 and RET : from neoplasia to neurogenesis

    Jordan R Hansford;Lois M Mulligan

  • Analysis of PTEN and the 10q23 region in primary prostate carcinomas.

    Harriet E Feilotter;Maria A Nagai;Alexander H Boag;Charis Eng

  • Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene

    Lois M. Mulligan;Charts Eng;Tanla Attlé;Stanislas Lyonnet

  • Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation

    Oliver Gimm;Debbie J. Marsh;Scott D. Andrew;Andrea Frilling

  • Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease

    Charis Eng;Lois M. Mulligan

  • Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.

    Shirley M. Myers;Charis Eng;Charis Eng;Bruce A J Ponder;Lois M. Mulligan

  • Heterogeneous Mutation of the RET Proto-oncogene in Subpopulations of Medullary Thyroid Carcinoma

    Charis Eng;Lois M. Mulligan;Catherine S. Healey;Carol Houghton

  • Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

    Charls Eng;Lois M. Mulligan;Lois M. Mulligan;Darrin P. Smith;Catherine S. Healey

  • Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma

    Charis Eng;Charis Eng;Lois M. Mulligan;Lois M. Mulligan;Darrin P. Smith;Catherine S. Healey

Frequent Co-Authors

Charis Eng
Charis Eng Cleveland Clinic Lerner College of Medicine
Bruce A.J. Ponder
Bruce A.J. Ponder University of Cambridge
Catherine S. Healey
Catherine S. Healey University of Cambridge
Bruce G. Robinson
Bruce G. Robinson University of Sydney
Bradley N. White
Bradley N. White Trent University
Stanislas Lyonnet
Stanislas Lyonnet Université Paris Cité
Patricia L. M. Dahia
Patricia L. M. Dahia The University of Texas Health Science Center at San Antonio
Alan Tunnacliffe
Alan Tunnacliffe University of Cambridge
John B.J. Kwok
John B.J. Kwok University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Genetics, several online degrees and career pathways in healthcare can help broaden your expertise and job prospects. Many genetics graduates pursue advanced nursing roles, as these often intersect with genetic counseling, patient education, and research.

For those interested in direct patient care and clinical leadership, an online nurse practitioner degree offers a flexible route to becoming a licensed practitioner, often with specializations relevant to genetics. Similarly, an online nursing school can provide foundational education and open doors to diverse roles in healthcare.

Nurses looking to advance their qualifications may explore msn to dnp programs online, which prepare professionals for leadership, research, and advanced practice. Additionally, for registered nurses, the cheapest online rn to bsn programs offer a cost-effective way to boost qualifications and enhance genetic literacy within nursing practice.

As genetics continues to transform personalized medicine, these online degree paths can help you align your education with the future of healthcare.

Best Scientists Citing Lois M. Mulligan

Trending Scientists

Recently Published Articles